Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis

Por Hobl, Eva-Luise, Jilma, Bernd, Erlacher, Ludwig, Mader, Robert
Publicado em 2010

Extravasation emergencies: state-of-the-art management and progress in clinical research

Por Pluschnig, Ursula, Haslik, Werner, Bartsch, Rupert, Mader, Robert M.
Publicado no Memo (2016)

Indocyanine Green Video Angiography Predicts Outcome of Extravasation Injuries

Por Haslik, Werner, Pluschnig, Ursula, Steger, Günther G., Zielinski, Christoph C., Schrögendorfer, K. F., Nedomansky, Jakob, Bartsch, Rupert, Mader, Robert M.
Publicado em 2014

Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel

Por Bartsch, Rupert, Steger, Guenther G, Forstner, Birgit, Wenzel, Catharina, Pluschnig, Ursula, Rizovski, Blanka, Altorjai, Gabriela, Zielinski, Christoph C, Mader, Robert M
Publicado em 2007

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment

Por Bartsch, Rupert, Wenzel, Catharina, Pluschnig, Ursula, Hussian, Dagmar, Sevelda, Ursula, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G
Publicado em 2006

Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study

Por Bartsch, Rupert, Wenzel, Catharina, Hussian, Dagmar, Pluschnig, Ursula, Sevelda, Ursula, Koestler, Wolfgang, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G
Publicado em 2006

Impaired Channel Targeting and Retinal Degeneration in Mice Lacking the Cyclic Nucleotide-Gated Channel Subunit CNGB1

Por Hüttl, Sabine, Michalakis, Stylianos, Seeliger, Mathias, Luo, Dong-Gen, Acar, Niyazi, Geiger, Heidi, Hudl, Kristiane, Mader, Robert, Haverkamp, Silke, Moser, Markus, Pfeifer, Alexander, Gerstner, Andrea, Yau, King-Wai, Biel, Martin
Publicado em 2005

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

Por Bartsch, Rupert, De Vries, Catharina, Pluschnig, Ursula, Dubsky, Peter, Bago-Horvath, Zsuzsanna, Gampenrieder, Simon P, Rudas, Margaretha, Mader, Robert M, Rottenfusser, Andrea, Wiltschke, Christoph, Gnant, Michael, Zielinski, Christoph C, Steger, Guenther G
Publicado em 2009

Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer

Por Bergen, Elisabeth, Berghoff, Anna S., Rudas, Margaretha, Dubsky, Peter, De Vries, Catharina, Sattlberger, Claudia, Mader, Robert M., Zagouri, Flora, Sparber, Cornelia, Fitzal, Florian, Gnant, Michael, Rottenfusser, Andrea, Zielinski, Christoph C., Preusser, Matthias, Steger, Guenther G., Bartsch, Rupert
Publicado no Breast Care (Basel) (2014)

Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca(2+) signalling

Por Stadler, Serena, Nguyen, Chi Huu, Schachner, Helga, Milovanovic, Daniela, Holzner, Silvio, Brenner, Stefan, Eichsteininger, Julia, Stadler, Mira, Senfter, Daniel, Krenn, Liselotte, Schmidt, Wolfgang M., Huttary, Nicole, Krieger, Sigurd, Koperek, Oskar, Bago-Horvath, Zsuzsanna, Brendel, Konstantin Alexander, Marian, Brigitte, de Wever, Oliver, Mader, Robert M., Giessrigl, Benedikt, Jäger, Walter, Dolznig, Helmut, Krupitza, Georg
Publicado no Cell Mol Life Sci (2016)